Catawba Valley Medical Center

Name :

Catawba Valley Medical Center

Address  :

810 Fairgrove Church Road SE

Town  :

Hickory

State  :

North Carolina

Country  :

USA

Post Code:

28602

Phone  :

828.326.3000

Web URL  :

Specialization
  • Anaesthesiology
  • Cardiology
  • Daibetes, Endocrinology
  • Dentistry
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Gynaecology
  • Hematologist
  • Internal Medicine
  • Maxillofacial Surgery
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Pain Management
  • Pathology Lab
  • Podiatry
  • Pulmonology
  • Urology
Facilities

Total Number Of Beds : 258


Description

About Us
Since 1967 Catawba Valley Medical Center has built strong relationships with the people businesses and communities throughout the Catawba Valley As the regions largest notforprofit community hospital it is our mission to improve the health status of the Catawba Valley

We do this by providing highquality healthcare services as well as by supporting organizations dedicated to improving our standard of livingWe exist to heal and comfort patients to promote and foster a healthier Catawba Valley and to assure access to health care to all who need it not to create profits and return dividends to shareholders

By continuing to work together we can improve the overall health status of the Catawba Valley and make our community an even better place to call home
Karmanos Cancer Center receives HealthGrades 2012 Outstanding Patient Experience Award

HealthGrades analyzed patient satisfaction data for 3837 hospitals in the country using Hospital Consumer Assessment of Healthcare Providers and Systems HCAHPS hospital survey data obtained from the Centers for Medicare and Medicaid Services CMS The information was compiled from surveys given to a random sample of patients who were discharged from ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More